IDEX Biometrics ASA Statistics
Total Valuation
IDXAF has a market cap or net worth of 39.43 million. The enterprise value is 39.60 million.
| Market Cap | 39.43M |
| Enterprise Value | 39.60M |
Important Dates
The next estimated earnings date is Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 38.32M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +749.51% |
| Shares Change (QoQ) | +40.91% |
| Owned by Insiders (%) | 19.58% |
| Owned by Institutions (%) | 6.94% |
| Float | 52.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 188.65 |
| PB Ratio | 14.93 |
| P/TBV Ratio | 18.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.62 |
| EV / Sales | 180.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.47.
| Current Ratio | 2.07 |
| Quick Ratio | 0.39 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.84 |
Financial Efficiency
Return on equity (ROE) is -260.95% and return on invested capital (ROIC) is -173.51%.
| Return on Equity (ROE) | -260.95% |
| Return on Assets (ROA) | -82.94% |
| Return on Invested Capital (ROIC) | -173.51% |
| Return on Capital Employed (ROCE) | -309.33% |
| Weighted Average Cost of Capital (WACC) | 17.89% |
| Revenue Per Employee | 9,952 |
| Profits Per Employee | -520,286 |
| Employee Count | 21 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.22 |
Taxes
| Income Tax | -163,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +900.00% in the last 52 weeks. The beta is 2.06, so IDXAF's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | +900.00% |
| 50-Day Moving Average | 60.32 |
| 200-Day Moving Average | 136.52 |
| Relative Strength Index (RSI) | 32.29 |
| Average Volume (20 Days) | 30 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDXAF had revenue of 209,000 and -10.93 million in losses. Loss per share was -0.44.
| Revenue | 209,000 |
| Gross Profit | -1.13M |
| Operating Income | -14.06M |
| Pretax Income | -11.09M |
| Net Income | -10.93M |
| EBITDA | -13.64M |
| EBIT | -14.06M |
| Loss Per Share | -0.44 |
Balance Sheet
The company has 1.06 million in cash and 1.23 million in debt, with a net cash position of -169,000.
| Cash & Cash Equivalents | 1.06M |
| Total Debt | 1.23M |
| Net Cash | -169,000 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.64M |
| Book Value Per Share | 0.05 |
| Working Capital | 3.90M |
Cash Flow
| Operating Cash Flow | -10.12M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -6,725.36% |
| Pretax Margin | -5,305.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IDXAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -749.51% |
| Shareholder Yield | -749.51% |
| Earnings Yield | -27.71% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 9, 2024. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jan 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
IDXAF has an Altman Z-Score of -2.36 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.36 |
| Piotroski F-Score | 1 |